来源：市场资讯（来源：你好张江）近日，科望医药创始人团队在杭州“国际免疫创新研讨会”上，向全球专家分享自研“巨噬细胞衔接器平台BiME”的最新进展。“优秀药企需具备国际创新能力与全球竞争力，行业同质化下，必须做‘全球新’产品并强化执行力，才能快速将创新转化为成果。”科望医药联合创始人兼CEO纪晓辉表示。这家在浦东成立8年的创新药企，专注肿瘤与自身免疫领域关键靶点，已构建具全球竞争力的免疫疗法管线，...
Source Link来源：市场资讯（来源：你好张江）近日，科望医药创始人团队在杭州“国际免疫创新研讨会”上，向全球专家分享自研“巨噬细胞衔接器平台BiME”的最新进展。“优秀药企需具备国际创新能力与全球竞争力，行业同质化下，必须做‘全球新’产品并强化执行力，才能快速将创新转化为成果。”科望医药联合创始人兼CEO纪晓辉表示。这家在浦东成立8年的创新药企，专注肿瘤与自身免疫领域关键靶点，已构建具全球竞争力的免疫疗法管线，...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.